Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
15.87
-0.30 (-1.86%)
Jul 11, 2025, 3:46 PM - Market open
Tandem Diabetes Care Employees
Tandem Diabetes Care had 2,650 employees as of December 31, 2024. The number of employees increased by 250 or 10.42% compared to the previous year.
Employees
2,650
Change (1Y)
250
Growth (1Y)
10.42%
Revenue / Employee
$370,925
Profits / Employee
-$69,383
Market Cap
1.06B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,650 | 250 | 10.42% |
| Dec 31, 2023 | 2,400 | -200 | -7.69% |
| Dec 31, 2022 | 2,600 | 600 | 30.00% |
| Dec 31, 2021 | 2,000 | 500 | 33.33% |
| Dec 31, 2020 | 1,500 | 457 | 43.82% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TNDM News
- 9 days ago - Tandem Diabetes Care to Announce Second Quarter 2025 Financial Results on August 6, 2025 - Business Wire
- 21 days ago - Tandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott's FreeStyle Libre® 3 Plus Sensor in the United States - Business Wire
- 4 weeks ago - Tandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone Sensor - Business Wire
- 2 months ago - Tandem Diabetes Care Announces Upcoming Conference Presentations - Business Wire
- 2 months ago - Tandem Diabetes Care, Inc. (TNDM) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 2 months ago - Tandem Diabetes Care Announces First Quarter 2025 Financial Results - Business Wire
- 3 months ago - Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025 - Business Wire
- 4 months ago - Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes - Business Wire